GALNT3 and renal cell carcinoma: GALNT3 is frequently up-regulated in renal cell carcinoma (RCC) and independently predicts high-grade tumor and poor survival [13]; similarly GALNT3 is also up-regulated in high-grade serous epithelial ovarian cancer (EOC) and is correlated with shorter progression-free survival in advanced stage EOC [14].